Who owns NGNE?
Institutional ownership of Neurogene Inc. from Form 13F, Q2 2026
112 institutional managers reported holding Neurogene Inc. (NGNE) in Form 13F filings for Q2 2026, with 17,312,171 shares worth $544M. The largest reported holder was Samsara Biocapital, LLC. Managers that filed both quarters added a net 343,687 shares (+2.0%). 22 opened new positions and 4 sold out.
- Funds holding
- 112
- Value held
- $544M
- New / sold out
- 22 / 4
- Net shares, same filers
- +2.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of NGNE
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Samsara Biocapital, LLC | $54.0M | 9.9% | 1,717,127 | Unchanged |
| Casdin Capital, LLC | $48.6M | 8.9% | 1,545,361 | Added |
| Redmile Group, LLC | $44.4M | 8.2% | 1,412,199 | Trimmed |
| RTW Investments, LP | $42.8M | 7.9% | 1,362,456 | Unchanged |
| EcoR1 Capital, LLC | $40.0M | 7.3% | 1,271,342 | Unchanged |
| BlackRock, Inc. | $33.3M | 6.1% | 1,057,983 | Added |
| Baker Bros. Advisors LP | $31.2M | 5.7% | 991,691 | Unchanged |
| Balyasny Asset Management L.P. | $25.7M | 4.7% | 818,706 | Added |
| Trails Edge Capital Partners, LP | $22.5M | 4.1% | 714,885 | Trimmed |
| Toronto Dominion Bank | $21.4M | 3.9% | 681,337 | Unchanged |
| Vanguard Capital Management LLC | $16.9M | 3.1% | 536,525 | Added |
| Jennison Associates LLC | $16.3M | 3.0% | 518,582 | Trimmed |
| Citadel Advisors LLC | $12.9M | 2.4% | 408,982 | Added |
| Great Point Partners LLC | $11.1M | 2.0% | 352,180 | Trimmed |
| ArrowMark Colorado Holdings LLC | $10.8M | 2.0% | 342,453 | Trimmed |
| FMR LLC | $9.3M | 1.7% | 295,561 | Trimmed |
| Geode Capital Management, LLC | $9.2M | 1.7% | 293,182 | Added |
| State Street Corp | $7.1M | 1.3% | 224,322 | Trimmed |
| Franklin Resources Inc | $6.4M | 1.2% | 204,280 | New |
| Morgan Stanley | $6.0M | 1.1% | 191,724 | Trimmed |
| UBS Group AG | $5.4M | 1.0% | 171,289 | Trimmed |
| Blair William & Co | $4.6M | 0.8% | 146,905 | Trimmed |
| Driehaus Capital Management LLC | $4.5M | 0.8% | 143,528 | Added |
| Point72 Asset Management, L.P. | $4.5M | 0.8% | 141,920 | New |
| Moore Capital Management, LP | $4.5M | 0.8% | 141,636 | New |
Share of 13F holdings is each fund's shares as a share of the 17,312,171 NGNE shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Franklin Resources Inc New+$6.4M
- Point72 Asset Management, L.P. New+$4.5M
- Moore Capital Management, LP New+$4.5M
- Casdin Capital, LLC Added+$3.9M
- Driehaus Capital Management LLC Added+$3.5M
- Balyasny Asset Management L.P. Added+$3.2M
- Trexquant Investment LP New+$2.3M
- BlackRock, Inc. Added+$1.7M
- DAFNA Capital Management LLC Added+$1.0M
- Wellington Management Group LLP New+$987K
Biggest sellers in Q2 2026
- ArrowMark Colorado Holdings LLC Trimmed-$5.7M
- Millennium Management LLC Trimmed-$5.1M
- Great Point Partners LLC Trimmed-$4.6M
- Morgan Stanley Trimmed-$2.9M
- State Street Corp Trimmed-$2.8M
- FMR LLC Trimmed-$2.7M
- Trails Edge Capital Partners, LP Trimmed-$2.1M
- Redmile Group, LLC Trimmed-$1.5M
- Renaissance Technologies LLC Trimmed-$723K
- Blair William & Co Trimmed-$670K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $42.4M and sold $31.3M; 37 added and 31 trimmed.
Schedule 13D and 13G filings on NGNE
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-10-07PRUDENTIAL FINANCIAL INC SCHEDULE 13G filed by Neurogene Inc.Schedule 13G
- 2026-10-06JENNISON ASSOCIATES LLC SCHEDULE 13G filed by Neurogene Inc.Schedule 13G
- 2026-08-14BALYASNY ASSET MANAGEMENT L.P. SCHEDULE 13G filed by Neurogene Inc.Schedule 13G
- 2025-05-15BAKER BROS. ADVISORS LP SCHEDULE 13G filed by Neurogene Inc.Schedule 13G
Questions about NGNE ownership
- Who owns NGNE stock?
- 112 institutional investment managers reported NGNE positions in their Form 13F filings for Q2 2026, holding 17,312,171 shares worth $544M in total. Samsara Biocapital, LLC reported the largest position.
- Are funds buying or selling NGNE?
- In Q2 2026, 22 managers opened new NGNE positions, 37 added, 31 trimmed and 4 sold out. Managers that filed in both quarters added a net 343,687 shares.
- How current is this NGNE institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to NGNE by CUSIP. Options are left out. NGNE news and filings · NGNE insider trades · Top funds